Summary of opinion: Cerdelga, 17/10/2024 Positive
Summary of opinion: Cerdelga, 17/10/2024 Positive
Summary of opinion: Cerdelga, 17/10/2024 Positive
Summary of opinion: Kevzara Positive
Summary of opinion: Yselty, 17/10/2024 Positive
Translarna: EMA re-confirms non-renewal of authorisation of Duchenne muscular dystrophy medicine
Summary of opinion: Tevimbra, 17/10/2024 Positive
Summary of opinion: Kisqali, 17/10/2024 Positive
Human medicines European public assessment report (EPAR): Zytiga, abiraterone, Date of authorisation: 05/09/2011, Revision: 28, Status: Authorised
Human medicines European public assessment report (EPAR): Velcade, bortezomib, Date of authorisation: 26/04/2004, Revision: 46, Status: Authorised
Medicinal products for human use: monthly figures - September 2024
Training webinar on Product Management Service (PMS) Product User Interface (PUI), Online, from 16 October 2024, 10:00 (CEST) to 16 October 2024, 11:00 (CEST)